Close Menu

University of Mississippi

The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.

By targeting a subclass of metastatic breast cancer cells called cancer stem-like cells, a team led by researchers at the Southern Illinois University School of Medicine has found a microRNA, miR-7, that appears to play a key role in brain-specific breast cancer metastasis.

QuantaLife has been awarded $820,000 in the first year of a five-year project with the University of Mississippi Medical Center to develop microdroplet PCR-based point-of-care tests to detect methicillin-resistant Staphylococcus aureus.

The ARIC Neurocognitive Study will employ brain imaging and new genetic technologies to gather information from thousands of patients, in addition to data collected through the past two decades by the Atherosclerosis Risk in Communities study into the risk factors associated with heart disease and stroke.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.